Fragiotta, Serena http://orcid.org/0000-0002-6214-6270
Fernández-Avellaneda, Pedro http://orcid.org/0000-0003-4668-7496
Breazzano, Mark P. http://orcid.org/0000-0002-7093-965X
Yannuzzi, Lawrence A. http://orcid.org/0000-0002-9463-6311
Curcio, Christine A. http://orcid.org/0000-0001-9769-1538
Freund, K. Bailey http://orcid.org/0000-0002-7888-9773
Article History
Received: 8 August 2019
Revised: 18 November 2019
Accepted: 10 December 2019
First Online: 26 December 2019
Compliance with ethical standards
:
: Serena Fragiotta declares that she has no conflict of interest. Pedro Fernández-Avellaneda declares that he has no conflict of interest. Mark P. Breazzano declares that he has no conflict of interest. Lawrence A. Yannuzzi declares that he has no conflict of interest. Christine A. Curcio receives research funding from Heidelberg Engineering and Hoffman La Roche; Department of Ophthalmology and Visual Science, University of Alabama at Birmingham receives institutional support from EyeSight Foundation of Alabama and Research to Prevent Blindness, Inc. K. Bailey Freund is a consultant to Genentech, Optovue, Zeiss, Heidelberg Engineering, Allergan, and Novartis. He receives research funding from Genentech/Roche.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.